Antares PharmaInc (NASDAQ:ATRS) Marks Movement With Q4 And Patent Troll

Antares PharmaInc (NASDAQ:ATRS) Marks Movement With Q4 And Patent Troll
Antares PharmaInc (NASDAQ:ATRS) has received approval from the Food and Drug Administration to market OTREXUP, a trademark drug which is used as an injection to treat multiple forms of rheumatoid arthritis, psoriasis, as well aspolyarticular idiopathic …
Read more on FinancialsTrend

Antares Pharma reports positive results from phase II Vibex QuickShot
Antares Pharma, Inc. has reported positive results from a multi-centre phase II clinical study evaluating the pharmacokinetic profile of testosterone enanthate administered once-weekly by subcutaneous injection at doses of 50 mg and 100 mg using the …
Read more on pharmabiz.com